Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adacel launch

Executive Summary

Sanofi-Aventis vaccine Adacel launches in the U.S. for booster immunization against tetanus, diphtheria and acellular pertussis in individuals aged 11-64, the company reports July 25. List price for Adacel is $33.50 per dose; vaccine is provided in packages containing 10-single dose vials. The Tdap vaccine cleared FDA June 10 with a postmarketing commitment for a 16,000-patient epidemiological safety surveillance study (1"The Pink Sheet," June 20, 2005, p. 20)...

You may also be interested in...

Sanofi’s Adacel Tdap Vaccine Receives Broader Approval Than GSK’s Boostrix

Sanofi-Aventis' postmarketing commitments for Adacel include a 16,000-patient epidemiologic safety surveillance study of the tetanus, diphtheria and acellular pertussis vaccine

ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva

The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.

FDA Sets New Restrictions For Authorized N95 Decontamination Systems

After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts